Larimar Therapeutics Inc
Biotechnology
Healthcare
LRMR
63.96 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.47
52 week high
9.29
high
4.63
52 week low
0.00
previous Close
4.48
P/E ratio
market cap
194 M
div yield
0
net incoming
-29.28 M
-1.59 %
net profit margin
-2928100000.00 %
11960.00 %
operating incoming
-31.19 M
0.34 %
net change in cash
-12.09 M
-368.32 %
cash on hand
21.13 M
-36.40 %
top